Related Experiment Video
Updated: Nov 4, 2025
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.2K
Imbalance Between Injury and Defense in the COPD Emphysematous Phenotype
1Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Frontiers in Medicine
|May 24, 2021
Summary
The chronic obstructive pulmonary disease (COPD) emphysematous phenotype involves lung tissue destruction, leading to poor prognosis and treatment resistance. Understanding the injury-defense imbalance is key to addressing this severe COPD subtype.
Area of Science:
- Pulmonary Medicine
- Pathophysiology
- Respiratory Diseases
Background:
- The emphysematous phenotype of chronic obstructive pulmonary disease (COPD) is marked by lung tissue destruction.
- These patients exhibit characteristic CT scan findings, higher mortality, and reduced response to standard therapies.
- The underlying pathogenesis of this COPD phenotype remains poorly understood, posing diagnostic and therapeutic challenges.
Purpose of the Study:
- To review the pathogenesis of the COPD emphysematous phenotype.
- To discuss the pathophysiological processes driving disease progression in this specific COPD subtype.
- To explore the role of injury and defense mechanism imbalance in emphysematous COPD.
Main Methods:
- Literature review focused on the pathogenesis of COPD emphysematous phenotype.
- Analysis of pathophysiological processes from an injury and defense imbalance perspective.
- Synthesis of current understanding regarding disease progression in emphysematous COPD.
Main Results:
- Emphysematous COPD is characterized by structural lung damage.
- Patients with this phenotype face worse outcomes and limited treatment options.
- An imbalance between injury and defense mechanisms is implicated in disease progression.
Conclusions:
- The pathogenesis of emphysematous COPD is complex and linked to injury-defense imbalance.
- Further research into these mechanisms is crucial for improved diagnostics and therapeutics.
- Targeting the injury-defense imbalance may offer new treatment strategies for emphysematous COPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.5K
01:22Chronic Obstructive Pulmonary Disease
1.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
01:20COPD: Pathogenesis and Clinical Features
1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
513
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
513